Rankings
▼
Calendar
PRTA Q4 2018 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$512M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$194,000
-15.3% YoY
Gross Profit
-$16M
-8410.3% margin
Operating Income
-$23M
-11729.4% margin
Net Income
-$22M
-11577.8% margin
EPS (Diluted)
$-0.56
QoQ Revenue Growth
-23.9%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$23M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$499M
Total Liabilities
$176M
Stockholders' Equity
$323M
Cash & Equivalents
$428M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$194,000
$229,000
-15.3%
Gross Profit
-$16M
-$33M
+51.0%
Operating Income
-$23M
-$47M
+51.9%
Net Income
-$22M
-$48M
+53.0%
← FY 2018
All Quarters
Q1 2019 →